Thomas C. Baghai

Regensburg, BY, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Neuropathophysiological changes associated with mirtazapine treatment response in major depressive disorder: insights into bottom-up dopaminergic pathways and prefrontal control networks.

Neuropathophysiological changes associated with mirtazapine treatment response in major depressive disorder: insights into bottom-up dopaminergic pathways and prefrontal control networks.

Journal: European archives of psychiatry and clinical neuroscience

Published: January 06, 2026

Short-term effects of etifoxine on human gut microbiome in healthy men.

Short-term effects of etifoxine on human gut microbiome in healthy men.

Journal: Frontiers in neuroscience

Published: March 17, 2023

Depressive Disorders in Adolescence: Current State of Studies Concerning the Microbiota-Gut-Brain Axis

Depressive Disorders in Adolescence: Current State of Studies Concerning the Microbiota-Gut-Brain Axis

Journal: Zeitschrift fur Kinder- und Jugendpsychiatrie und Psychotherapie

Published: February 08, 2023

Effect of Minocycline on Depressive Symptoms in Patients With Treatment-Resistant Depression: A Randomized Clinical Trial.

Effect of Minocycline on Depressive Symptoms in Patients With Treatment-Resistant Depression: A Randomized Clinical Trial.

Journal: JAMA network open

Published: September 14, 2022

Induced neural progenitor cells and iPS-neurons from major depressive disorder patients show altered bioenergetics and electrophysiological properties.

Induced neural progenitor cells and iPS-neurons from major depressive disorder patients show altered bioenergetics and electrophysiological properties.

Journal: Molecular psychiatry

Published: May 20, 2021

Mental health-related risk factors and interventions in patients with heart failure: a position paper endorsed by the European Association of Preventive Cardiology (EAPC).

Mental health-related risk factors and interventions in patients with heart failure: a position paper endorsed by the European Association of Preventive Cardiology (EAPC).

Journal: European journal of preventive cardiology

Published: September 03, 2020

SARS-CoV-2 Risk Management in Clinical Psychiatry: A Few Considerations on How to Deal With an Unrivaled Threat.

SARS-CoV-2 Risk Management in Clinical Psychiatry: A Few Considerations on How to Deal With an Unrivaled Threat.

Journal: Frontiers in psychiatry

Published: April 14, 2020

Major Depressive Disorder is Associated with Impaired Mitochondrial Function in Skin Fibroblasts.

Major Depressive Disorder is Associated with Impaired Mitochondrial Function in Skin Fibroblasts.

Journal: Cells

Published: March 11, 2020

The cytokine IL-17A as a marker of treatment resistance in major depressive disorder?

The cytokine IL-17A as a marker of treatment resistance in major depressive disorder?

Journal: The European journal of neuroscience

Published: June 28, 2019

Minocycline alters behavior, microglia and the gut microbiome in a trait-anxiety-dependent manner.

Minocycline alters behavior, microglia and the gut microbiome in a trait-anxiety-dependent manner.

Journal: Translational psychiatry

Published: March 05, 2019

"I Am I and My Bacterial Circumstances": Linking Gut Microbiome, Neurodevelopment, and Depression.

"I Am I and My Bacterial Circumstances": Linking Gut Microbiome, Neurodevelopment, and Depression.

Journal: Frontiers in psychiatry

Published: June 22, 2017

Macrophage-Derived Chemokine: A Putative Marker of Pharmacological Therapy Response in Major Depression?

Macrophage-Derived Chemokine: A Putative Marker of Pharmacological Therapy Response in Major Depression?

Journal: Neuroimmunomodulation

Published: June 14, 2017

Showing 1-12 of 29

Last Updated: 09/26/2026